CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
Botulinum toxin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02909907
NCT02909907N/ACompleted

Comparison of Botulinum Toxin Injections in Forearm FLexor Plus EXtensor Muscles Versus Flexor Muscles Alone for the Treatment of Essential Hand Tremor (FLEX-D ET)

The Cleveland Clinic·interventional·Posted Sep 21, 2016·Updated May 8, 2019

In Brief

A clinical study evaluating Botulinum toxin and Placebo for Essential Tremor. Completed, enrolled 21 participants across 1 site.

Detailed Summary

To compare the efficacy of botulinum toxin (BoNT) injections in forearm flexors plus extensor muscles versus flexors alone for the treatment of essential hand tremor (ET).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 21, 2016
Enrollment StartAug 1, 2016
Primary CompletionFeb 1, 2018
Study CompletionFeb 28, 2018
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.8 years ago

Interventions

Botulinum toxindrug

Botulinum injections into dominant upper extremity using protocol outlined above.

Placeboother

Placebo injections in extensor carpi radialis (ECR) and extensor carpi ulnaris (ECU) per protocol outlined above